[
{
"old_id":"1",
"old_nametree":"Authors and legal information",
"old_numtree":"1.0.0.0",
"old_htmlpage":"ENAS5265_1.0.0.0",
"new_id":"1",
"new_nametree":"Authors and legal information",
"new_numtree":"1.0.0.0",
"new_htmlpage":"ENAS5265_1.0.0.0"
},
{
"old_id":"2",
"old_nametree":"Risk factors for VTE",
"old_numtree":"2.0.0.0",
"old_htmlpage":"null",
"new_id":"2",
"new_nametree":"Risk factors for VTE",
"new_numtree":"2.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"3",
"old_nametree":"Overview",
"old_numtree":"2.1.0.0",
"old_htmlpage":"ENAS5265_2.1.0.0",
"new_id":"3",
"new_nametree":"Overview",
"new_numtree":"2.1.0.0",
"new_htmlpage":"ENAS5265_2.1.0.0"
},
{
"old_id":"4",
"old_nametree":"Chemotherapy-associated VTE",
"old_numtree":"2.2.0.0",
"old_htmlpage":"ENAS5265_2.2.0.0",
"new_id":"4",
"new_nametree":"Chemotherapy-associated VTE",
"new_numtree":"2.2.0.0",
"new_htmlpage":"ENAS5265_2.2.0.0"
},
{
"old_id":"5",
"old_nametree":"Diagnosis of occult cancer idiopathic VTE",
"old_numtree":"3.0.0.0",
"old_htmlpage":"ENAS5265_3.0.0.0",
"new_id":"5",
"new_nametree":"Diagnosis of occult cancer idiopathic VTE",
"new_numtree":"3.0.0.0",
"new_htmlpage":"ENAS5265_3.0.0.0"
},
{
"old_id":"6",
"old_nametree":"Prevention of VTE in patients with cancer",
"old_numtree":"4.0.0.0",
"old_htmlpage":"null",
"new_id":"6",
"new_nametree":"Prevention of VTE in patients with cancer",
"new_numtree":"4.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"7",
"old_nametree":"Surgical patients",
"old_numtree":"4.1.0.0",
"old_htmlpage":"ENAS5265_4.1.0.0",
"new_id":"7",
"new_nametree":"Surgical patients",
"new_numtree":"4.1.0.0",
"new_htmlpage":"ENAS5265_4.1.0.0"
},
{
"old_id":"8",
"old_nametree":"Medical patients",
"old_numtree":"4.2.0.0",
"old_htmlpage":"ENAS5265_4.2.0.0",
"new_id":"8",
"new_nametree":"Medical patients",
"new_numtree":"4.2.0.0",
"new_htmlpage":"ENAS5265_4.2.0.0"
},
{
"old_id":"9",
"old_nametree":"Treatment of VTE in solid tumours",
"old_numtree":"5.0.0.0",
"old_htmlpage":"null",
"new_id":"9",
"new_nametree":"Treatment of VTE in solid tumours",
"new_numtree":"5.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"10",
"old_nametree":"Acute treatment",
"old_numtree":"5.1.0.0",
"old_htmlpage":"null",
"new_id":"10",
"new_nametree":"Acute treatment",
"new_numtree":"5.1.0.0",
"new_htmlpage":"null"
},
{
"old_id":"11",
"old_nametree":"LMWH and UFH",
"old_numtree":"5.1.1.0",
"old_htmlpage":"ENAS5265_5.1.1.0",
"new_id":"11",
"new_nametree":"LMWH and UFH",
"new_numtree":"5.1.1.0",
"new_htmlpage":"ENAS5265_5.1.1.0"
},
{
"old_id":"12",
"old_nametree":"Thrombolytic therapy",
"old_numtree":"5.1.2.0",
"old_htmlpage":"ENAS5265_5.1.2.0",
"new_id":"12",
"new_nametree":"Thrombolytic therapy",
"new_numtree":"5.1.2.0",
"new_htmlpage":"ENAS5265_5.1.2.0"
},
{
"old_id":"13",
"old_nametree":"Long-term treatment",
"old_numtree":"5.2.0.0",
"old_htmlpage":"ENAS5265_5.2.0.0",
"new_id":"13",
"new_nametree":"Long-term treatment",
"new_numtree":"5.2.0.0",
"new_htmlpage":"ENAS5265_5.2.0.0"
},
{
"old_id":"14",
"old_nametree":"Duration of Tx to prevent VTE recurr.",
"old_numtree":"5.3.0.0",
"old_htmlpage":"ENAS5265_5.3.0.0",
"new_id":"14",
"new_nametree":"Duration of Tx to prevent VTE recurr.",
"new_numtree":"5.3.0.0",
"new_htmlpage":"ENAS5265_5.3.0.0"
},
{
"old_id":"15",
"old_nametree":"Treatment of recurrent VTE",
"old_numtree":"5.4.0.0",
"old_htmlpage":"ENAS5265_5.4.0.0",
"new_id":"15",
"new_nametree":"Treatment of recurrent VTE",
"new_numtree":"5.4.0.0",
"new_htmlpage":"ENAS5265_5.4.0.0"
},
{
"old_id":"16",
"old_nametree":"Use of a vena cava filter",
"old_numtree":"5.5.0.0",
"old_htmlpage":"ENAS5265_5.5.0.0",
"new_id":"16",
"new_nametree":"Use of a vena cava filter",
"new_numtree":"5.5.0.0",
"new_htmlpage":"ENAS5265_5.5.0.0"
},
{
"old_id":"17",
"old_nametree":"Contraindications to anticoagulation",
"old_numtree":"6.0.0.0",
"old_htmlpage":"ENAS5265_6.0.0.0",
"new_id":"17",
"new_nametree":"Contraindications to anticoagulation",
"new_numtree":"6.0.0.0",
"new_htmlpage":"ENAS5265_6.0.0.0"
},
{
"old_id":"18",
"old_nametree":"Anticoagulation and prognosis",
"old_numtree":"7.0.0.0",
"old_htmlpage":"ENAS5265_7.0.0.0",
"new_id":"18",
"new_nametree":"Anticoagulation and prognosis",
"new_numtree":"7.0.0.0",
"new_htmlpage":"ENAS5265_7.0.0.0"
},
{
"old_id":"19",
"old_nametree":"Summary of recommendations",
"old_numtree":"8.0.0.0",
"old_htmlpage":"null",
"new_id":"19",
"new_nametree":"Summary of recommendations",
"new_numtree":"8.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"20",
"old_nametree":"Risk factors for VTE",
"old_numtree":"8.1.0.0",
"old_htmlpage":"ENAS5265_8.1.0.0",
"new_id":"20",
"new_nametree":"Risk factors for VTE",
"new_numtree":"8.1.0.0",
"new_htmlpage":"ENAS5265_8.1.0.0"
},
{
"old_id":"21",
"old_nametree":"Diagnosis of occult cancer idiopathic VTE",
"old_numtree":"8.2.0.0",
"old_htmlpage":"ENAS5265_8.2.0.0",
"new_id":"21",
"new_nametree":"Diagnosis of occult cancer idiopathic VTE",
"new_numtree":"8.2.0.0",
"new_htmlpage":"ENAS5265_8.2.0.0"
},
{
"old_id":"22",
"old_nametree":"Prevention of VTE in patients with cancer",
"old_numtree":"8.3.0.0",
"old_htmlpage":"null",
"new_id":"22",
"new_nametree":"Prevention of VTE in patients with cancer",
"new_numtree":"8.3.0.0",
"new_htmlpage":"null"
},
{
"old_id":"23",
"old_nametree":"Surgical patients",
"old_numtree":"8.3.1.0",
"old_htmlpage":"ENAS5265_8.3.1.0",
"new_id":"23",
"new_nametree":"Surgical patients",
"new_numtree":"8.3.1.0",
"new_htmlpage":"ENAS5265_8.3.1.0"
},
{
"old_id":"24",
"old_nametree":"Medical patients",
"old_numtree":"8.3.2.0",
"old_htmlpage":"ENAS5265_8.3.2.0",
"new_id":"24",
"new_nametree":"Medical patients",
"new_numtree":"8.3.2.0",
"new_htmlpage":"ENAS5265_8.3.2.0"
},
{
"old_id":"25",
"old_nametree":"Treatment of VTE in solid tumours",
"old_numtree":"8.4.0.0",
"old_htmlpage":"null",
"new_id":"25",
"new_nametree":"Treatment of VTE in solid tumours",
"new_numtree":"8.4.0.0",
"new_htmlpage":"null"
},
{
"old_id":"26",
"old_nametree":"Acute treatment",
"old_numtree":"8.4.1.0",
"old_htmlpage":"null",
"new_id":"26",
"new_nametree":"Acute treatment",
"new_numtree":"8.4.1.0",
"new_htmlpage":"null"
},
{
"old_id":"27",
"old_nametree":"LMWH and UFH",
"old_numtree":"8.4.1.1",
"old_htmlpage":"ENAS5265_8.4.1.1",
"new_id":"27",
"new_nametree":"LMWH and UFH",
"new_numtree":"8.4.1.1",
"new_htmlpage":"ENAS5265_8.4.1.1"
},
{
"old_id":"28",
"old_nametree":"Thrombolytic therapy",
"old_numtree":"8.4.1.2",
"old_htmlpage":"ENAS5265_8.4.1.2",
"new_id":"28",
"new_nametree":"Thrombolytic therapy",
"new_numtree":"8.4.1.2",
"new_htmlpage":"ENAS5265_8.4.1.2"
},
{
"old_id":"29",
"old_nametree":"Long-term treatment",
"old_numtree":"8.4.2.0",
"old_htmlpage":"ENAS5265_8.4.2.0",
"new_id":"29",
"new_nametree":"Long-term treatment",
"new_numtree":"8.4.2.0",
"new_htmlpage":"ENAS5265_8.4.2.0"
},
{
"old_id":"30",
"old_nametree":"Duration of Tx to prevent VTE recurr.",
"old_numtree":"8.4.3.0",
"old_htmlpage":"ENAS5265_8.4.3.0",
"new_id":"30",
"new_nametree":"Duration of Tx to prevent VTE recurr.",
"new_numtree":"8.4.3.0",
"new_htmlpage":"ENAS5265_8.4.3.0"
},
{
"old_id":"31",
"old_nametree":"Treatment of recurrent VTE",
"old_numtree":"8.4.4.0",
"old_htmlpage":"ENAS5265_8.4.4.0",
"new_id":"31",
"new_nametree":"Treatment of recurrent VTE",
"new_numtree":"8.4.4.0",
"new_htmlpage":"ENAS5265_8.4.4.0"
},
{
"old_id":"32",
"old_nametree":"Use of vena cava filter",
"old_numtree":"8.4.5.0",
"old_htmlpage":"ENAS5265_8.4.5.0",
"new_id":"32",
"new_nametree":"Use of vena cava filter",
"new_numtree":"8.4.5.0",
"new_htmlpage":"ENAS5265_8.4.5.0"
},
{
"old_id":"33",
"old_nametree":"Contraindications to anticoagulation",
"old_numtree":"8.5.0.0",
"old_htmlpage":"ENAS5265_8.5.0.0",
"new_id":"33",
"new_nametree":"Contraindications to anticoagulation",
"new_numtree":"8.5.0.0",
"new_htmlpage":"ENAS5265_8.5.0.0"
},
{
"old_id":"34",
"old_nametree":"Glossary",
"old_numtree":"9.0.0.0",
"old_htmlpage":"ENAS5265_9.0.0.0",
"new_id":"34",
"new_nametree":"Glossary",
"new_numtree":"9.0.0.0",
"new_htmlpage":"ENAS5265_9.0.0.0"
}
]